All data are based on the daily closing price as of May 1, 2026
b

BML

4694.TSE
23.98 USD
0.03
+0.13%

Overview

Last close
23.98 usd
Market cap
898.79M usd
52 week high
27.88 usd
52 week low
17.41 usd
Target price
28.66 usd

Valuation

P/E
20.6183
Forward P/E
12.4844
Price/Sales
0.9441
Price/Book Value
1.1194
Enterprise Value
511.65M usd
EV/Revenue
0.6275
EV/EBITDA
4.6851

Key financials

Revenue TTM
949.48M usd
Gross Profit TTM
305.87M usd
EBITDA TTM
120.37M usd
Earnings per Share
1.16 usd
Dividend
0.7 usd
Total assets
1.13B usd
Net debt
-385.75M usd

About

BML, Inc. provides contract clinical testing and related services in Japan. The company offers a range of laboratory testing, such as biochemical and hematologic examination; laboratory test, including tumor markers, infectious diseases, hormones, cellular immunity, genetics, bacteriological tests, and other test; specialized testing in oncology, infectious diseases, diabetes, hypertension, allergies, genetics, and more areas, as well as develops Frontier and Symphony automation systems, which automate pre-testing from specimen sorting to dispensing. It also provides contract clinical testing, including endocrine, plasma protein, biochemical, viral, immunoserological, hematological, cellular immunity, bacteriological, and histopathological, pathological, and cytological tests; specimen receiving service; and medical information system services, which include electronic medical charts for clinics without beds. In addition, the company is involved in manufacturing and supply services for medical equipment and supplies; real estate leasing and insurance agency business; providing food hygiene inspection and food consulting services; and dispensing pharmacy services. The company was incorporated in 1955 and is headquartered in Tokyo, Japan.
  • Symbol
    4694.TSE
  • Exchange
    TSE
  • Isin
    JP3799700004
  • Country
    Japan
  • Sector
    Healthcare
  • Industry
    Diagnostics & Research
  • CEO
  • Headquarter
    Tokyo
  • Web site
    https://www.bml.co.jp
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top